Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    18465317 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: Epirubicin, cyclophosphamide and docetaxel;   Drug: docetaxel, cyclophosphamide

Study has passed its completion date and status has not been verified in more than two years.